Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CRISPR-Cas knockout of miR21 reduces glioma growth

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.04.001Source: DataRank Database

CRISPR-Cas knockout of miR21 reduces glioma growth is a research paper published in Molecular Therapy — Oncolytics (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access48 citations

Download PDF

Cite:

Linked data & code

geo gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 3.88)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Thomas S. van Solinge ORCID,Pike-See Cheah ORCID,Liza Morsett,Joseph El Khoury ORCID,Joseph I. Rissman ORCID

Live enrichment

PubMed:35572197 PMC:PMC9052041 OpenAlex:https://openalex.org/W4226181990

NCI NIH HHS

Grant: R00 CA218870

NINDS NIH HHS

Grant: R56 NS123271

NHLBI NIH HHS

Grant: P01 HL142494

NCI NIH HHS

Grant: R35 CA232103

NCI NIH HHS

Grant: U19 CA179563

NCI NIH HHS

Grant: P01 CA069246

National Institutes of Health

Grant: 3U19CA179563-02S1

exRNA released by glioblastoma alters brain microenvironment

National Institutes of Health

Grant: 5P01HL142494-02

Hematopoiesis in cardiovascular disease

National Institutes of Health

Grant: 5R00CA218870-04

Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing

National Institutes of Health

Grant: 5R35CA232103-04

The power of extracellular vesicles in glioblastoma

National Institutes of Health

Grant: 3P01CA069246-03S1

OPTIMIZATION OF CYTOCHROME P450

Stichting De Drie Lichten

Margaret Q Landenberger Research Foundation

NIH

Bontius Stichting

FWCI

3.88

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.cell.com/article/S2372770522000535/pdf

publisherhttp://www.cell.com/article/S2372770522000535/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2372770522000535?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2372770522000535?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omto.2022.04.001

Fields of Study

MicroRNA in disease regulationCRISPR and Genetic EngineeringRNA regulation and disease0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

microRNAGliomaCRISPRBiologyDownregulation and upregulationGeneCancer researchRegulation of gene expressionCell growthComputational biologyLong non-coding RNACell biologyGeneticsGlioblastomaMir-21Gene EditingMicroRNA Regulation in Cancer and DevelopmentMicroRNA ProcessingClustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteinsRNA-GuidedBiochemistry, Genetics and Molecular BiologyCRISPR SystemsMolecular BiologyRC254-282Neoplasms. Tumors. Oncology. Including cancer and carcinogensLife SciencesMultiplex Genome EditingFunctions and Regulation of RNA Editing by ADARsFOS: Biological sciencesOriginal ArticleRNA Editing

Sustainable Development Goals

SDG 0: Good health and well-being

CRISPR-Cas knockout of miR21 reduces glioma growth

FAIR Checklist

Authors (10)

Funding (15 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)